Short Interest in InspireMD Inc (NSPR) Decreases By 2.5%

Share on StockTwits

InspireMD Inc (NYSEAMERICAN:NSPR) was the recipient of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 1,431,668 shares, a drop of 2.5% from the January 15th total of 1,468,850 shares. Based on an average daily volume of 1,576,725 shares, the short-interest ratio is currently 0.9 days. Approximately 4.4% of the company’s shares are short sold.

InspireMD stock opened at $0.18 on Thursday. InspireMD has a 52 week low of $0.13 and a 52 week high of $7.80.

An institutional investor recently raised its position in InspireMD stock. Virtu Financial LLC increased its position in InspireMD Inc (NYSEAMERICAN:NSPR) by 1,305.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 291,021 shares of the medical equipment provider’s stock after purchasing an additional 270,318 shares during the period. Virtu Financial LLC owned about 0.77% of InspireMD worth $46,000 at the end of the most recent reporting period.

COPYRIGHT VIOLATION NOTICE: “Short Interest in InspireMD Inc (NSPR) Decreases By 2.5%” was first posted by Week Herald and is the property of of Week Herald. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at

InspireMD Company Profile

InspireMD, Inc, a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions.

See Also: Correction

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with's FREE daily email newsletter.

Leave a Reply